Stryker Corp. expects a roughly 6% to 8% annual sales increase on an organic basis and warned of pandemic-related volatility.
The company, which previously pointed to labor and staffing shortages in healthcare, on Thursday said it expects an adjusted profit for the year of $9.60 to $10 a share and said that foreign currency exchange rates could have a moderate benefit on profit and sales.
The company said it expects unfavorable price reductions of about 1% in 2022.
Analysts surveyed by FactSet expect an adjusted profit of $10.16 a share and about $18.31 billion in revenue.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.